Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial

出版年份 2017 全文链接

标题

作者

关键词

出版物

LANCET ONCOLOGY

Volume 18, Issue 6, Pages 743-754

出版商

Elsevier BV

发表日期

2017-05-17

DOI

10.1016/s1470-2045(17)30313-3

向作者/读者发起求助以获取更多资源

Protocol

在线求助

Reagent

在线求助

Reprint

联系作者

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.